HOUSTON--(BUSINESS WIRE)--IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new muscle with full length dystrophin in Becker ...
Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...
In this collaboration project, we will create these universal cells from iPS cells, and Vita will use them for cell transplantation therapy in FSHD patients What is a DMF (Drug Master File) A DMF ...
With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without ...
A quirk in the metabolism of immature heart muscle cells can be leveraged to deliver a pure stream of the cells perfect for regenerative medicine applications, researchers in Japan have found. The ...
Explore how researchers developed a new method for freezing iPS cells without losing their undifferentiated state.
PALO ALTO, Calif., July 10, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. ( https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback